MHRA AI projects aim to use artificial intelligence and NHS data to predict side effects from drug combinations before they reach patients. The technology is still in development. The paperwork has already achieved the rare medical breakthrough of arriving before the symptoms.
MHRA AI projects meet the regulator
The Medicines and Healthcare products Regulatory Agency announced three government backed projects on 22 October 2025. The work aims to modernise how medicines and medical technologies are tested and approved.
One study will examine anonymised NHS data for patterns in cardiovascular drug combinations. Researchers will then test possible signals in laboratory models. Those models mimic how the body processes medicines.
This use of data could help researchers understand interactions earlier. It could give doctors better evidence in future. It could also make every committee form a subcommittee to define the word future.
The first project has £859,650 from the Government’s AI Capability Fund. Two others will pilot AI assisted tools for regulatory advice, trial assessments and licensing decisions. The programme also covers synthetic patient data for trials.
Innovation gets a lanyard
MHRA AI projects are not magic machines that have already prevented harm. They are projects, pilots and approaches. A deployed system must work. A pilot can produce a learning outcome and several meetings about that outcome.
Polly Podium, fictional deputy director of Premature Confidence, praised the plan. She said the model will identify risk before reality sends an invoice. Humans will still make decisions. Those humans will also approve the minutes.
The announcement describes more than £2 million in support for the three projects. It says the work will inform guidance for developers and future regulatory decisions.
The projects may make regulation faster, safer and more consistent. For now, bureaucracy has looked at the future and asked it to complete a form in triplicate before filing an appeal.
Source: Medicines and Healthcare products Regulatory Agency.
